Hypochondroplasia - 1 Studies Found
| Active, not recruiting |
: Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children : Hypochondroplasia : 2010-04-23 : Drug: Recombinant human growth hormone (Somatropin) Recombinant human growth hormone (Somatropin) will b |